🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Are selected #HepC-associated indolent #lymphoma curable with antivirals only? See our new article from MD Anderson Cancer Center OncoAlert IDSA ESCMID EORTC CDC Hepatitis HHS_ViralHep EASLnews @esgvh2023 The ASCO Post ASH AASLD onlinelibrary.wiley.com/doi/10.1002/ho…

Excellent workshop on long-acting treatments against #HepB sponsored by NIAID News at the #GHS2025 #HepatitisElimination #IDTwitter #GITwitter @esgvh2023 IDSA ESCMID CDC Hepatitis HHS_ViralHep EASLnews AASLD

Outstanding #GHS2025 meeting. Awesome presentations and networking with those working on #HepatitisElimination of the carcinogenic #HepB and #HepC #endcancer #IDTwitter #GITwitter @esgvh2023 IDSA ESCMID CDC Hepatitis HHS_ViralHep EASLnews AASLD

New Let's Talk ID out now! Paul Sax speaks with Adam Ratner, MD, MPH, Professor of Pediatrics and Microbiology at @NYUGrossman, about the rise of vaccines preventable diseases. Available wherever you listen to podcasts. Transcript: bit.ly/4bLdDNb

#GHS2027 will be hosted at the Melbourne Convention and Exhibition Centre, thanks to a successful bid by the MelbConventionBureau in partnership with the Burnet Institute and Doherty Institute. We look forward to seeing you! #GlobalHepatitisSummit #GHS2027 #Melbourne2027

Thank you AASLD! There are huge disparities in hepatitis screening and treatment. Many patients have limited access to care. It’s crucial we continue working to provide care to communities and individual who are too often overlooked. BCM Gastroenterology Project ECHO

Interested to expand your knowledge on #HBV and #HCV management during #pregnancy? 💡🤰👩‍⚕️ Join us on 24 April at 15.00 CEST for a webinar featuring @ESGVH experts 📅💻🎉 Register for free, at the link below: lnkd.in/d2cvyYC7 ESCMID, Laura Ambra Nicolini, Dr. Sumit Rawat

🌍 #ESCMIDGlobal 2025 has officially kicked off in Vienna! Day 1 starts early, with our chair Oana Sandulescu featured in a Special Session. Exciting #ID #CM #Science days ahead! 📅Don’t miss out. Download your personalized @ESGVH programme! ↓↓↓ ESCMID

Congratulations to the European Study Group for Viral Hepatitis (ESGVH) ESCMID on being ranked N#1 among the study groups in 2025. Excited to have the #HepC Special Interest Group AASLD collaborating with this great team @esgvh2023 IDSA EASLnews #ESCMIDGlobal

Harrys Torres ESCMID AASLD IDSA EASLnews As @ESGVH we truly cherish the collaboration with #HepC Special Interest Group AASLD ESCMID Moving science further together 🤝

Now through May 6, #AASLD is accepting public comments for the proposed recommendations in the AASLD Practice Guideline on Treatment of Chronic #HepatitisB. Submit your comments today! wkf.ms/3Y2gMma

🛑 Stigma stops care. It's time to end it. EASL’s newly released #PolicyStatement is a powerful Call to Action: Everyone deserves dignity, respect, and access to liver care, free from blame and discrimination. Stigma around liver diseases like hepatitis, ArLD, and MASLD

For one month only, read the #AASLD special collection "High Impact Papers 2024-2025" online at no additional cost in HEPATOLOGY Journal. Digestive Disease Week #DDW2025 Harmeet Malhi bit.ly/4diPChj

Honored to speak at the XVII National Viral Hepatitis Congress of Turkiye on #HepC #HepatitisElimination #endcancer #IDTwitter #GITwitter IDSA CDC Hepatitis HHS_ViralHep EASLnews AASLD @ESGVH ESCMID World Health Organization (WHO)

Today is #HepatitisTesting Day—a reminder that early detection saves lives. Get tested, know your status, and take charge of your #liverhealth. 🧪💚#TestTreatCure

Don’t miss this upcoming collaborative webinar hosted in Spanish by AASLD and ALEH! This session will cover: ✅ Simplified treatment regimens ✅ Monitoring strategies ✅ Drug interactions ✅ Management of #HCV in cancer patients Register today: bit.ly/3FcKaQa

My sincere congratulations to the Viral Hepatitis Society of Turkiye for their excellent National Congress in Mugla. I was honored to be invited to present on behalf of #ESGVH in a fantastic session together with Dr Harrys Torres and amazing moderators. ESCMID @ESGVH

Proud to be partnering with the Viral Hepatitis Society of Turkiye to deliver high quality content at their National Congress. Exceptional meeting, incredible faculty! Dr Oana Sandulescu Dr Harrys Torres Dr Nurcan Baykam Dr Imran Hasanoglu @ESGVH ESCMID

Wonderful experience today speaking on #HepC at the XVII National Viral Hepatitis Congress of Turkiye. Fantastic meeting with great organization from our colleagues in #Turkey #endcancer #HepatitisElimination IDSA EASLnews AASLD APASL News @ESGVH ESCMID

Join the free webinar on #HepC in Latin America and North America sponsored by AASLD and ALEH. Únase al webinar gratuito sobre HepC en Latinoamérica y Norteamérica de AASLD/ALEH. #HepatitisElimination #endcancer Register-Regístrese bit.ly/3FcKaQa